ALEMBIC PHARMACEUTICALS
Back to Income Statement
|
ALEMBIC PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹616 Cr | ₹342 Cr | ₹521 Cr | ₹1,147 Cr | ₹829 Cr |
What is the latest Consolidated Net Profit of ALEMBIC PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹616 Cr |
| Mar2024 | ₹342 Cr |
| Mar2023 | ₹521 Cr |
| Mar2022 | ₹1,147 Cr |
| Mar2021 | ₹829 Cr |
How is Consolidated Net Profit of ALEMBIC PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹616 Cr | 80.07 | |
| Mar2024 | ₹342 Cr | -34.35 | |
| Mar2023 | ₹521 Cr | -54.56 | |
| Mar2022 | ₹1,147 Cr | 38.33 | |
| Mar2021 | ₹829 Cr | - | |
Compare Consolidated Net Profit of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹16,172.3 Cr | 4.6% | 14.2% | -16.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | 4.6% |
14.2% |
-16.3% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses